ODDB.org: Open Drug Database

Swissmedic Registration	68690	Date of registration	13.07.2022
Company name	Samsung Bioepis CH GmbH	Revision date
		Valid until	12.07.2027
Indication		Date of market entry
Index Therapeuticus (BSV)	11.99.	Revocation Date
Index Therapeuticus (Swissmedic)	11.99.	Information for professionals	IP

Seq.-No.	Product	Description	Galenic form	ATC-classification
01	Byooviz 10 mg / mL	Injektionslösung in Durchstechflasche	Injection solution (Ranibizumab 10 mg/ml)	S01LA04

2025	©ywesee GmbH